MiRus announced new early feasibility study results supporting the use of its Siegel transcatheter aortic valve replacement ...

Transcatheter aortic valve implantation (TAVI) is now an established treatment option for elderly patients with severe ...

Dapagliflozin reduced the risk of all-cause mortality or worsening heart failure by 28% in patients with aortic stenosis ...

About this study The objective of ENVISION is to evaluate the safety and effectiveness of the Navitor Transcatheter Aortic Valve Implantation (TAVI) System for treating patients with symptomatic, ...

In EARLY TAVR, intervention improved outcomes over waiting in patients with class II or no indications for AVR consideration.